Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-03-2009 | Article

Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance

Authors: E. Fréalle, K. Decrucq, F. Botterel, B. Bouchindhomme, D. Camus, E. Dei-Cas, J. M. Costa, I. Yakoub-Agha, S. Bretagne, L. Delhaes

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 3/2009

Abstract

In order to improve invasive pulmonary aspergillosis (IPA) diagnosis, a real-time polymerase chain reaction (PCR) assay detecting Aspergillus spp. was developed. Its detection limit reached 2–20 conidia. The retrospective evaluation on 64 bronchoalveolar lavage (BAL) fluids from 57 patients at risk for IPA, including 20 probable and five proven IPA patients, revealed a 88% or 38% sensitivity in direct examination (DE)/culture-positive or culture-negative BAL, respectively, whereas galactomannan (GM) sensitivity reached 88% or 58%, respectively. Influence on the Aspergillus-PCR yield of BAL fluid volume, cellular count and DNA content (evaluated by human β-globin quantification) was assessed. Significantly higher β-globin levels were detected in Aspergillus PCR-positive (median 5,112 pg/μl) than negative (median 1,332 pg/μl) BAL fluids, suggesting that the β-globin level could reflect BAL yields and DNA extraction. Using β-globin for the interpretation of fungal PCR could improve the negative predictive value of this test.

Pagano L, Girmenia C, Mele L, Ricci P, Tosti ME, Nosari A et al (2001) Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program. Haematologica 86(8):862–870PubMed

Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F et al (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34(1):7–14. doi:10.1086/323335 PubMedCrossRef

Hope WW, Walsh TJ, Denning DW (2005) Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 5(10):609–622. doi:10.1016/S1473-3099(05)70238-3 PubMedCrossRef

Verdaguer V, Walsh TJ, Hope W, Cortez KJ (2007) Galactomannan antigen detection in the diagnosis of invasive aspergillosis. Expert Rev Mol Diagn 7(1):21–32. doi:10.1586/14737159.7.1.21 PubMedCrossRef

Tarrand JJ, Lichterfeld M, Warraich I, Luna M, Han XY, May GS et al (2003) Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 119(6):854–858. doi:10.1309/EXBVYAUPENBM285Y PubMedCrossRef

Aquino VR, Goldani LZ, Pasqualotto AC (2007) Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis. Mycopathologia 163(4):191–202. doi:10.1007/s11046-007-9010-2 PubMedCrossRef

Mennink-Kersten MA, Donnelly JP, Verweij PE (2004) Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 4(6):349–357. doi:10.1016/S1473-3099(04)01045-X PubMedCrossRef

Tanriover MD, Metan G, Altun B, Hascelik G, Uzun O (2005) False positivity for Aspergillus antigenemia related to the administration of piperacillin/tazobactam. Eur J Intern Med 16(7):489–491. doi:10.1016/j.ejim.2005.04.007 PubMedCrossRef

Dalle F, Charles PE, Blanc K, Caillot D, Chavanet P, Dromer F et al (2005) Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan. J Clin Microbiol 43(6):2929–2931. doi:10.1128/JCM.43.6.2929-2931.2005 PubMedCrossRef

10.

Becker MJ, Lugtenburg EJ, Cornelissen JJ, Van Der Schee C, Hoogsteden HC, De Marie S (2003) Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 121(3):448–457. doi:10.1046/j.1365-2141.2003.04308.x PubMedCrossRef

11.

Costa C, Costa JM, Desterke C, Botterel F, Cordonnier C, Bretagne S (2002) Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J Clin Microbiol 40(6):2224–2227. doi:10.1128/JCM.40.6.2224-2227.2002 PubMedCrossRef

12.

Einsele H, Hebart H, Roller G, Löffler J, Rothenhofer I, Müller CA et al (1997) Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 35(6):1353–1360PubMed

13.

Ferrer C, Colom F, Frasés S, Mulet E, Abad JL, Alió JL (2001) Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections. J Clin Microbiol 39(8):2873–2879. doi:10.1128/JCM.39.8.2873-2879.2001 PubMedCrossRef

14.

Halliday C, Wu QX, James G, Sorrell T (2005) Development of a nested qualitative real-time PCR assay to detect Aspergillus species DNA in clinical specimens. J Clin Microbiol 43(10):5366–5368. doi:10.1128/JCM.43.10.5366-5368.2005 PubMedCrossRef

15.

Skladny H, Buchheidt D, Baust C, Krieg-Schneider F, Seifarth W, Leib-Mösch C et al (1999) Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J Clin Microbiol 37(12):3865–3871PubMed

16.

Spiess B, Buchheidt D, Baust C, Skladny H, Seifarth W, Zeilfelder U et al (2003) Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients. J Clin Microbiol 41(5):1811–1818. doi:10.1128/JCM.41.5.1811-1818.2003 PubMedCrossRef

17.

Bretagne S, Costa JM, Marmorat-Khuong A, Poron F, Cordonnier C, Vidaud M et al (1995) Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol 33(5):1164–1168PubMed

18.

Buchheidt D, Baust C, Skladny H, Ritter J, Suedhoff T, Baldus M et al (2001) Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis 33(4):428–435. doi:10.1086/321887 PubMedCrossRef

19.

Raad I, Hanna H, Huaringa A, Sumoza D, Hachem R, Albitar M (2002) Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of Aspergillus in BAL. Chest 121(4):1171–1176. doi:10.1378/chest.121.4.1171 PubMedCrossRef

20.

Rantakokko-Jalava K, Laaksonen S, Issakainen J, Vauras J, Nikoskelainen J, Viljanen MK et al (2003) Semiquantitative detection by real-time PCR of Aspergillus fumigatus in bronchoalveolar lavage fluids and tissue biopsy specimens from patients with invasive aspergillosis. J Clin Microbiol 41(9):4304–4311. doi:10.1128/JCM.41.9.4304-4311.2003 PubMedCrossRef

21.

Sanguinetti M, Posteraro B, Pagano L, Pagliari G, Fianchi L, Mele L et al (2003) Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 41(8):3922–3925. doi:10.1128/JCM.41.8.3922-3925.2003 PubMedCrossRef

22.

Verweij PE, Latgé JP, Rijs AJ, Melchers WJ, De Pauw BE, Hoogkamp-Korstanje JA et al (1995) Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol 33(12):3150–3153PubMed

23.

Tuon FF (2007) A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberoam Micol 24(2):89–94PubMedCrossRef

24.

Papanicolaou Society of Cytopathology Task Force on Standard Practice (1999) Guidelines of the papanicolaou society of cytopathology for the examination of cytologic specimens obtained from the respiratory tract. Diagn Cytopathol 21(1):61–69. doi:10.1002/(SICI)1097-0339(199907)21:1<61::AID-DC17>3.0.CO;2-O CrossRef

25.

Chamberlain DW, Braude AC, Rebuck AS (1987) A critical evaluation of bronchoalveolar lavage. Criteria for identifying unsatisfactory specimens. Acta Cytol 31(5):599–605PubMed

26.

Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA (2004) Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 42(12):5517–5522. doi:10.1128/JCM.42.12.5517-5522.2004 PubMedCrossRef

27.

Durand-Joly I, Chabé M, Soula F, Delhaes L, Camus D, Dei-Cas E (2005) Molecular diagnosis of Pneumocystis pneumonia. FEMS Immunol Med Microbiol 45(3):405–410. doi:10.1016/j.femsim.2005.06.006 PubMedCrossRef

28.

Bolehovska R, Pliskova L, Buchta V, Cerman J, Hamal P (2006) Detection of Aspergillus spp. in biological samples by real-time PCR. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150(2):245–248PubMed

29.

Millon L, Piarroux R, Deconinck E, Bulabois CE, Grenouillet F, Rohrlich P et al (2005) Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis. J Clin Microbiol 43(10):5097–5101. doi:10.1128/JCM.43.10.5097-5101.2005 PubMedCrossRef

30.

Martín Juan J, Valenzuela Mateos F, Soto Campos G, Segado Soriano A, Rodríguez Panadero F, Castillo Gómez J (1996) Quality and selection of samples of bronchoalveolar lavage (BAL) in diffuse pneumopathies. Arch Bronconeumol 32(7):332–340PubMed

31.

Griffiths LJ, Anyim M, Doffman SR, Wilks M, Millar MR, Agrawal SG (2006) Comparison of DNA extraction methods for Aspergillus fumigatus using real-time PCR. J Med Microbiol 55(Pt 9):1187–1191. doi:10.1099/jmm.0.46510-0 PubMedCrossRef

32.

Löffler J, Hebart H, Schumacher U, Reitze H, Einsele H (1997) Comparison of different methods for extraction of DNA of fungal pathogens from cultures and blood. J Clin Microbiol 35(12):3311–3312PubMed

33.

Khot PD, Ko DL, Hackman RC, Fredricks DN (2008) Development and optimization of quantitative PCR for the diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. BMC Infect Dis 8(1):73. doi:10.1186/1471-2334-8-73 PubMedCrossRef

34.

Löffler J, Henke N, Hebart H, Schmidt D, Hagmeyer L, Schumacher U et al (2000) Quantification of fungal DNA by using fluorescence resonance energy transfer and the light cycler system. J Clin Microbiol 38(2):586–590

35.

Francesconi A, Kasai M, Harrington SM, Beveridge MG, Petraitiene R, Petraitis V et al (2008) Automated and manual methods of DNA extraction for Aspergillus fumigatus and Rhizopus oryzae analyzed by quantitative real-time PCR. J Clin Microbiol 46(6):1978–1984PubMedCrossRef

36.

Bretagne S, Costa JM (2005) Towards a molecular diagnosis of invasive aspergillosis and disseminated candidosis. FEMS Immunol Med Microbiol 45(3):361–368. doi:10.1016/j.femsim.2005.05.012 PubMedCrossRef

37.

Francesconi A, Kasai M, Petraitiene R, Petraitis V, Kelaher AM, Schaufele R et al (2006) Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J Clin Microbiol 44(7):2475–2480. doi:10.1128/JCM.02693-05 PubMedCrossRef

38.

Vallor AC, Kirkpatrick WR, Najvar LK, Bocanegra R, Kinney MC, Fothergill AW et al (2008) Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Antimicrob Agents Chemother 52(7):2593–2598. doi:10.1128/AAC.00276-08 PubMedCrossRef

39.

Meersseman W, Lagrou K, Maertens J, Wilmer A, Hermans G, Vanderschueren S et al (2008) Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 177(1):27–34. doi:10.1164/rccm.200704-606OC PubMedCrossRef

40.

Lachnik J, Ackermann B, Bohrssen A, Maass S, Diephaus C, Puncken A et al (2002) Rapid-cycle PCR and fluorimetry for detection of mycobacteria. J Clin Microbiol 40(9):3364–3373. doi:doi:10.1128/JCM.40.9.3364-3373.2002 PubMedCrossRef

Title: Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance
Authors: E. Fréalle
K. Decrucq
F. Botterel
B. Bouchindhomme
D. Camus
E. Dei-Cas
J. M. Costa
I. Yakoub-Agha
S. Bretagne
L. Delhaes
Publication date: 01-03-2009
Publisher: Springer-Verlag
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-008-0616-1

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real-time PCR performance

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2009

Identification of protein candidates for the serodiagnosis of Q fever endocarditis by an immunoproteomic approach

A foodborne outbreak of a group A streptococcal infection in a Japanese university hospital

Quantitative variations in the vaginal bacterial population associated with asymptomatic infections: a real-time polymerase chain reaction study

Severe adenovirus community-acquired pneumonia mimicking Legionella

Rapid detection of bla KPC -positive Klebsiella pneumoniae in a clinical setting

Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page